Lothian, United Kingdom

Alan Archibald

This inventor holds 1 USPTO granted patent. Top assignee: The University of Edinburgh. Active years: 2018.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Alan Archibald: Innovator in Antiviral Compositions

Introduction

Alan Archibald is a notable inventor based in Lothian, GB. He has made significant contributions to the field of veterinary medicine, particularly in the prevention and treatment of viral diseases in animals. His work focuses on innovative methods that can enhance animal health and welfare.

Latest Patents

Alan Archibald holds a patent for "Domain 5 of CD163 for use in antiviral compositions against PRRS, and transgenic animals." This invention relates to methods and compositions that are useful for the prevention and/or treatment of Porcine Reproductive and Respiratory Syndrome (PRRS) in animals, particularly domestic pigs. The patent encompasses proteins that comprise fragments of CD163, nucleic acid constructs encoding such proteins, and methods for modifying the expression or activity of CD163 in vivo. He has 1 patent to his name.

Career Highlights

Alan Archibald is affiliated with the University of Edinburgh, where he contributes to research and development in veterinary sciences. His work has been instrumental in advancing the understanding of viral infections in livestock, which is crucial for the agricultural sector.

Collaborations

He has collaborated with notable colleagues such as Simon Geoffrey Lillico and Christopher Bruce Alexander Whitelaw. Their combined expertise has furthered research efforts in the field of veterinary virology.

Conclusion

Alan Archibald's innovative work in antiviral compositions represents a significant advancement in veterinary medicine. His contributions are vital for improving animal health and addressing challenges in livestock management.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…